SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer
Patients with high-grade serous ovarian cancer (HGSOC) have a very poor overall survival. Current therapeutic approaches do not bring benefit to all patients. Although genetic alterations and molecular mechanisms are well characterized, the molecular pathological conditions are poorly investigated....
Saved in:
Main Authors: | Stephanie Koller (Author), Jonatan Kendler (Author), Jasmine Karacs (Author), Andrea Wolf (Author), Caroline Kreuzinger (Author), Isabel Von Der Decken (Author), Felicitas Mungenast (Author), Diana Mechtcheriakova (Author), Wolfgang Schreiner (Author), Andreas Gleiss (Author), Walter Jäger (Author), Dan Cacsire Castillo-Tong (Author), Theresia Thalhammer (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer
by: Martin Svoboda, et al.
Published: (2018) -
Resveratrol Inhibits Key Steps of Steroid Metabolism in a Human Estrogen-Receptor Positive Breast Cancer Model: Impact on Cellular Proliferation
by: Stefan Poschner, et al.
Published: (2018) -
Toward pharmacogenetic SLCO1B1‐guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model
by: Zachary L. Taylor, et al.
Published: (2021) -
Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis
by: Kohei Ninomiya, et al.
Published: (2022) -
Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children
by: Li Q, et al.
Published: (2019)